Phase 3 Transformation Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 3
ALLG CLL10/CLLRT2: A prospective, open-label, randomised, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R-(mini)-CHOP for treatment of patients with Richter Transformation
CancerChronic Lymphocytic Leukemia (CLL)Richter Transformation
Australasian Leukaemia and Lymphoma Group116 enrolled7 locationsACTRN12625000965404
Recruiting
Phase 3
Thrombolysis in Factor Xa-inhibitors Trial
StrokeAcute Ischemic StrokeIschemic Stroke+6 more
Guri Hagberg300 enrolled13 locationsNCT06878066